SalaryGuide
AboutPricingFor Employers

Marketing jobs

5 marketing jobs

CareDx, Inc. logo
2 weeks ago

Director Marketing CTT

CareDx, Inc.

Brisbane, CA (Hybrid)Full time$250K/yr – $270K/yr
CareDx, Inc. logo
4 weeks ago

Brand Marketing Manager

CareDx, Inc.

Brisbane, CA (Remote)Full time$84K/yr – $125K/yr
CareDx, Inc. logo
3 months ago

Brand Marketing Manager

CareDx, Inc.

Brisbane, CA (On-site)Full time$94K/yr – $125K/yr
CareDx, Inc. logo
4 months ago

Corporate Communications Summer Intern 2026

CareDx, Inc.

Brisbane, CA (On-site)Volunteer$20/hr – $25/hr
CareDx, Inc. logo
4 months ago

Senior Manager, Commercial Technology & CRM

CareDx, Inc.

Brisbane, CA (On-site)Full time$135K/yr – $175K/yr

All marketing roles in the US

Get alerts for this search

All marketing roles in the US

Get alerts for this search

5 jobs
CareDx, Inc. logo

Director Marketing CTT

CareDx, Inc.

Brisbane, CA (Hybrid)

$250K/yr - $270K/yrIn-houseFull-timeSenior level
2 weeks ago
CareDx, Inc. logo

Brand Marketing Manager

CareDx, Inc.

Brisbane, CA (Remote)

$84K/yr - $125K/yrIn-houseFull-timeMid level3+ years exp.
4 weeks ago
CareDx, Inc. logo

Brand Marketing Manager

CareDx, Inc.

Brisbane, CA (On-site)

$94K/yr - $125K/yrIn-houseFull-timeMid level3+ years exp.
3 months ago
CareDx, Inc. logo

Corporate Communications Summer Intern 2026

CareDx, Inc.

Brisbane, CA (On-site)

$20/hr - $25/hrIn-houseVolunteerIntern/new grad
4 months ago
CareDx, Inc. logo

Senior Manager, Commercial Technology & CRM

CareDx, Inc.

Brisbane, CA (On-site)

$135K/yr - $175K/yrIn-houseFull-timeSenior level
4 months ago
CareDx, Inc. logo
CareDx, Inc.

Director Marketing CTT

Brisbane, CA (Hybrid)

$250K/yr – $270K/yrSenior LevelFull time

Posted 2 weeks ago

Top 1% of applicants do these two things.

The other 99% submit and hope. You're about to do something different.

Job Summary

Own the AlloHeme brand strategy and market development, leading launch planning, promotional strategy, cross-functional collaboration, and ongoing optimization across post-transplant monitoring workflows.

Job Description

Responsibilities

  • Brand Strategy & Franchise Development – Develop and execute the brand strategy for AlloHeme. Establish CareDx’s differentiated positioning in CTT by building on the company’s transplant leadership while addressing the unique needs of bone marrow transplant and cell therapy centers. Translate market research, competitive intelligence, KOL feedback, customer insights, and commercial priorities into clear strategic plans and compelling messages that support launch readiness, market shaping, and long-term franchise growth.
  • AlloHeme Launch Planning & Execution – Lead marketing planning and execution for the launch of AlloHeme, including core messaging, sales materials, digital content, conference presence, peer-to-peer education, PR/communications support, customer-facing resources, and field pull-through tools. Partner closely with cross-functional teams to ensure launch tactics are aligned with clinical data, customer needs, market access considerations, operational workflows, and CareDx brand standards.
  • Promotional Strategy & Tactic Development – Develop compelling, compliant promotional strategies and materials for key stakeholder audiences, including hem/onc transplant physicians, lab directors, clinical leadership, transplant administrators, value analysis committees, and other decision makers. Lead creation of sales aids, speaker decks, email campaigns, web content, conference assets, brochures, and other print/digital resources in collaboration with digital and operational marketing.
  • Market Development & Customer Engagement – Drive initiatives that increase awareness of CareDx in the CTT setting and support adoption of AlloHeme as part of post-transplant monitoring workflows. Develop programs that communicate the unmet need in post-HCT AML/MDS surveillance, the value of blood-based monitoring, and the importance of standardized relapse surveillance approaches. Partner with Medical Affairs and Sales to support compliant KOL engagement, advisory boards, congress activities, and educational initiatives.
  • Pipeline & Commercial Readiness Support – Work closely with the CTT product lead and cross-functional partners to develop commercial readiness plans for additional pipeline assets and potential future CTT offerings. Support market assessment, product positioning, customer segmentation, target audience definition, launch sequencing, value proposition development, and early tactical planning for assets beyond AlloHeme, including future molecular testing and/or wraparound solutions as applicable.
  • Cross-Functional Collaboration – Serve as a key marketing partner across Product, Sales, Medical Affairs, Marketing Operations, Events, Corporate Communications, Digital, Sales Training, Customer Experience, Market Access, and Compliance. Ensure CTT marketing initiatives are coordinated across internal teams and executed with clear timelines, ownership, and accountability. Partner closely with Sales Training to ensure the field team is equipped to deliver consistent, accurate, and compelling messages.
  • Agency & Vendor Management – Manage third-party agencies, creative partners, market research vendors, and other external partners supporting CTT marketing initiatives. Provide clear strategic briefs, direction, feedback, and approvals to ensure deliverables are high quality, clinically accurate, on brand, compliant, and delivered on time. Ensure agency work is aligned to launch priorities, budget, and business objectives.
  • Events, Conferences & Communications – Partner with Events and Corporate Communications to support CTT presence at key congresses and launch-related milestones. Lead conference strategy including development of key messaging for booth, product theaters, and customer engagement materials. Partner with corporate communications on earned/paid media campaigns and with medical on KOL-facing outreach. Ensure all external communications reinforce CareDx’s CTT strategy and brand positioning.
  • Insights, Metrics & Optimization – Track marketing effectiveness using appropriate KPIs, including awareness, engagement, field utilization, lead generation, account activation, campaign performance, adoption metrics, and customer feedback. Use insights from field team, market research, customers, and cross-functional partners to refine messaging, optimize tactics, and inform future planning.
  • Compliance, Budget & Operational Excellence – Lead marketing materials through the MLR review process, ensuring accuracy, compliance, and timely approvals. Manage marketing budgets, purchase orders, agency scopes, and project timelines. Balance speed, quality, and compliance while maintaining discipline around priorities and resource allocation.

Requirements

  • Marketing Experience –at least 10+ years of relevant marketing experience in diagnostics, genomics, biotech, pharma, medical device, or other regulated healthcare/life sciences environments. Experience developing brand strategy, launch plans, customer messaging, promotional materials, and multichannel marketing campaigns is required.
  • Launch & Market Development Experience – Demonstrated experience launching new products, building emerging markets, or establishing a new brand/franchise is strongly preferred. Experience in complex specialty markets with multiple clinical, laboratory, administrative, and financial stakeholders is highly relevant. The ideal candidate is comfortable creating clarity in ambiguity and developing marketing programs for products that require both clinical belief-building and operational workflow integration.
  • Health Care/Life Sciences – Experience in a regulated healthcare environment is required, ideally in diagnostics, genomics, transplant medicine, hematology/oncology, or molecular testing. Familiarity with HIPAA, data privacy, MLR review, clinical evidence translation, and compliant promotional practices is required. Experience in hematologic malignancies, cell therapy, MRD, or complex laboratory services is a strong plus.
  • Leadership & Cross-Functional Collaboration - must be a strong peer leader, self-starter, and collaborator that works effectively across Product, Sales, Medical, and Regulatory to ensure promotional content is clinically accurate, compliant, and strategically aligned. The ideal candidate excels at turning strategy into action, driving alignment across stakeholder groups, and executing initiatives that support both revenue growth and improved patient outcomes. Success in this role requires the ability to effectively collaborate and thrive in a matrixed, mission-driven organization.
  • Clinical & Scientific Communication – Proven ability to translate complex clinical, scientific, and technical information into clear, compelling, audience-specific messaging for HCPs, lab directors, administrators, sales teams, and other stakeholders. Must be able to balance scientific accuracy with commercial clarity and avoid over-claiming in a highly regulated environment.
  • Agency, Budget & Executional Excellence – Experience managing external agencies, vendors, creative development, media/digital programs, conference assets, and marketing budgets. Must be comfortable moving from strategy to execution, managing multiple workstreams simultaneously, and ensuring deliverables are completed on time and to a high standard.

Preferred

  • MBA, MPH, MS, or other advanced degree preferred.
  • Scientific or clinical background is a plus, particularly in molecular diagnostics, hematology/oncology, transplant medicine, genomics, or cell therapy.

Benefits

  • Competitive base salary and incentive compensation
  • Health and welfare benefits, including a gym reimbursement program
  • 401(k) savings plan match
  • Employee Stock Purchase Plan
  • Pre-tax commuter benefits
  • And more!
  • Please refer to our page to view detailed benefits at https://caredx.com/company/careers
  • Living Donor Employee Recovery Policy that allows up to 30 days of paid leave annually to a full-time employee who makes the selfless act of donating an organ or bone marrow.
CareDx, Inc. logo

CareDx, Inc.

2.6 Glassdoor

CareDx, Inc., headquartered in South San Francisco, is a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. Our Mission: Create life-changing solutions that enable transplant patients to thrive.Our Vision: A world where every patient receives the transplant they need to live longer, fuller lives. For more information, visit www.caredx.com.

Founded in 1998
Brisbane, California, USA
www.caredx.com
36% recommend to a friend

Traffic Signals

Monthly Google Ads Budget
$4

Marketing Team

Median Career Experience
17 years
Median Tenure
1.5 years
Marketing Roles Posted (Last 30 Days)
2

People

Founders / CEO

John Hanna
John Hanna
Chief Executive Officer
At the company for 2 years 4 months

HR / Recruitment

Gina Wasielewski
Gina Wasielewski
Director, Head of Talent Acquisition
At the company for 1 year 2 months
Tiffany Shih
Tiffany Shih
Sr Mgr, Head of Talent Acquisition
At the company for 2 years

Marketing Leadership

Julie Garlikov
Julie Garlikov
VP of Global Marketing
At the company for 1 year 7 months
Gina Wasielewski
Gina Wasielewski
Director, Head of Talent Acquisition
At the company for 1 year 2 months
Tiffany Shih
Tiffany Shih
Sr Mgr, Head of Talent Acquisition
At the company for 2 years
Troy Knapp
Troy Knapp
Senior Director, Head of Talent Acquisition
At the company for 4 years 6 months

Funding

Total Funding
$574.9M
Last Raise
$164M
Post IPO Equity, 5 years ago

Funding History

  • Jan 2021
    Post IPO Equity • $164M
  • Jun 2020
    Post IPO Equity • $117.1M
  • Nov 2018
    Post IPO Equity • $52.8M

Recent News

CDNA: Wells Fargo Raises Price Target to $18, Maintains Equal-We
Dec 15, 2025 • GuruFocus
CareDx price target raised to $18 from $14 at Wells Fargo
Dec 15, 2025 • TipRanks
CareDx (CDNA): Rethinking Valuation After a Sharp Short-Term Share Price Rebound
Dec 14, 2025 • Yahoo Finance UK
Nikko Asset Management Americas Inc. Reduces Position in CareDx, Inc. $CDNA
Dec 14, 2025 • MarketBeat
CareDx Shares Navigate Conflicting Market Signals
Dec 13, 2025 • AD HOC NEWS
There's No Escaping CareDx, Inc's (NASDAQ:CDNA) Muted Revenues Despite A 26% Share Price Rise
Dec 13, 2025 • 富途牛牛
CareDx, Inc. $CDNA Shares Sold by Bellevue Group AG
Dec 13, 2025 • MarketBeat
CareDx (NASDAQ:CDNA) Lowered to "Hold" Rating by Wall Street Zen
Dec 13, 2025 • MarketBeat
CareDx Reforms Get Nod Following $20 Million Investor Class Deal
Dec 10, 2025 • Bloomberg Law News
Next Century Growth Investors LLC Purchases 850,580 Shares of CareDx, Inc. $CDNA
Dec 10, 2025 • MarketBeat
Ophir Asset Management Pty Ltd Buys 274,625 Shares of CareDx, Inc. $CDNA
Dec 10, 2025 • MarketBeat
New York State Common Retirement Fund Acquires 64,175 Shares of CareDx, Inc. $CDNA
Dec 10, 2025 • MarketBeat
CareDx, Inc. $CDNA Shares Bought by Hood River Capital Management LLC
Dec 8, 2025 • MarketBeat
CareDx, Inc. $CDNA Shares Sold by Divisadero Street Capital Management LP
Dec 8, 2025 • MarketBeat
Russell Investments Group Ltd. Has $5.06 Million Stock Holdings in CareDx, Inc. $CDNA
Dec 6, 2025 • MarketBeat
CareDx, Inc's (NASDAQ:CDNA) Shares Bounce 25% But Its Business Still Trails The Industry
Nov 29, 2025 • simplywall.st
Wall Street Analysts Believe CareDx (CDNA) Could Rally 28.02%: Here's is How to Trade
Nov 27, 2025 • Yahoo Finance
CareDx (NASDAQ:CDNA) Upgraded at Zacks Research
Nov 21, 2025 • Defense World
Is CareDx Inc stock trading near support levels - Portfolio Value Summary & AI Based Buy/Sell Signal Reports
Nov 16, 2025 • newser.com
Is CareDx Inc stock trading near support levels - July 2025 Drop Watch & Reliable Price Breakout Alerts
Nov 15, 2025 • newser.com
Trend analysis for CareDx Inc this week - July 2025 Volume & AI Driven Price Forecasts
Nov 15, 2025 • newser.com
What is the fair value estimate for CareDx Inc (1K9) stock in 2025 - July 2025 Momentum & AI Powered Market Trend Analysis
Nov 14, 2025 • newser.com
Can CareDx Inc (1K9) stock expand revenue streams - 2025 Bull vs Bear & Technical Pattern Based Buy Signals
Nov 14, 2025 • newser.com
Is CareDx Inc stock trading near support levels - 2025 Geopolitical Influence & Risk Controlled Daily Trade Plans
Nov 14, 2025 • newser.com
Can CareDx Inc (1K9) stock expand revenue streams - July 2025 Analyst Calls & Intraday High Probability Setup Alerts
Nov 13, 2025 • newser.com
Can CareDx Inc (1K9) stock expand revenue streams - Trend Reversal & Expert Verified Stock Movement Alerts
Nov 13, 2025 • newser.com
Why CareDx Inc (1K9) stock remains stable - Weekly Profit Analysis & Long-Term Safe Investment Plans
Nov 13, 2025 • newser.com
Why CareDx Inc (1K9) stock remains stable - Profit Target & Free High Return Stock Watch Alerts
Nov 12, 2025 • newser.com
Trend analysis for CareDx Inc this week - July 2025 Market Mood & Low Drawdown Investment Strategies
Nov 12, 2025 • newser.com
We Believe CareDx's (NASDAQ:CDNA) Earnings Are A Poor Guide For Its Profitability
Nov 12, 2025 • simplywall.st
Why CareDx Inc (1K9) stock remains stable - Weekly Gains Report & Free Daily Entry Point Trade Alerts
Nov 12, 2025 • newser.com
We Believe CareDx's (NASDAQ:CDNA) Earnings Are A Poor Guide For Its Profitability
Nov 12, 2025 • Sahm
What is the fair value estimate for CareDx Inc (1K9) stock in 2025 - Portfolio Performance Report & Free Accurate Trade Setup Notifications
Nov 12, 2025 • newser.com
Trend analysis for CareDx Inc this week - Market Volume Report & Free Community Consensus Stock Picks
Nov 10, 2025 • newser.com
CareDx to Participate in Upcoming Investor Conferences
Nov 10, 2025 • The Globe and Mail
Will CareDx Inc (1K9) stock keep high P E multiples - July 2025 Short Interest & Fast Entry and Exit Trade Plans
Nov 10, 2025 • newser.com
CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Nov 7, 2025 • The Joplin Globe
CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Nov 7, 2025 • Markets Financial Content
CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Nov 7, 2025 • Business Wire
CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Nov 7, 2025 • Yahoo Finance
CareDx, Inc (NASDAQ:CDNA) Q3 2025 Earnings Call Transcript
Nov 6, 2025 • Insider Monkey
BTIG Maintains CareDx (CDNA) Buy Recommendation
Nov 6, 2025 • Nasdaq
CareDx Announces New Precision Kidney Transplant Data and Product Innovations at ASN Kidney Week 2025
Nov 6, 2025 • Yahoo Finance
CareDx Announces New Precision Kidney Transplant Data and Product Innovations at ASN Kidney Week 2025
Nov 6, 2025 • Business Wire
CareDx (CDNA): Profit Driven by $89.4 Million One-Off Gain Raises Earnings Sustainability Questions
Nov 6, 2025 • Sahm
CareDx raises 2025 revenue guidance to $372M–$376M with robust RCM gains and new product launches
Nov 5, 2025 • MSN
CareDx Inc. Reports Strong Q3 Earnings Growth
Nov 5, 2025 • TipRanks
CareDx (CDNA) Turns Profitable on $89.4M One-Off Gain, Challenging Quality of Earnings Narrative
Nov 5, 2025 • Yahoo Finance
CareDx Q3 2025 presentation slides: Revenue up 21%, guidance raised despite market caution
Nov 5, 2025 • Investing.com Nigeria
CareDx Inc (CDNA) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and Raised Guidance By GuruFocus
Nov 5, 2025 • Investing.com Canada
CareDx Reports Strong Q3 2025 Financial Results
Nov 5, 2025 • TipRanks
CareDx Q3 2025 presentation slides: Revenue up 21%, guidance raised despite market caution
Nov 4, 2025 • Investing.com UK
Caredx Inc earnings beat by $0.36, revenue topped estimates
Nov 4, 2025 • Investing.com UK
Transplant diagnostics firm CareDx Q3 revenue beats estimates, helped by new product launches
Nov 4, 2025 • MarketScreener
CareDx Reports Strong Q3 Financial Results
Nov 4, 2025 • TipRanks
CareDx (NASDAQ: CDNA) raises revenue guidance to $372–$376M; lifts EBITDA outlook
Nov 4, 2025 • Stock Titan
CareDx (CDNA) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
Nov 4, 2025 • Yahoo Finance
CareDx Q3 2025 presentation slides: Revenue up 21%, guidance raised despite market caution
Nov 4, 2025 • Investing.com
CareDx Inc (CDNA) Q3 2025 Earnings Report Preview: What To Expect
Nov 3, 2025 • Yahoo Finance
Transplant expert Dr. Teuteberg joins CareDx as chief medical officer By Investing.com
Oct 27, 2025 • Investing.com Nigeria
CareDx Announces Appointment of Jeffrey John Teuteberg, MD as Chief Medical Officer
Oct 27, 2025 • The Joplin Globe
CareDx Announces Appointment of Jeffrey John Teuteberg, MD as Chief Medical Officer
Oct 27, 2025 • Business Wire
CareDx, Inc Appoints Jeffrey John Teuteberg as Chief Medical Officer, Effective October 1, 2025
Oct 27, 2025 • MarketScreener
Transplant expert Dr. Teuteberg joins CareDx as chief medical officer
Oct 27, 2025 • Investing.com
CareDx Appoints Suresh Gunasekaran as New Director
Oct 24, 2025 • TipRanks
CareDx Announces Largest Landmark Study of Its Kind on Antibody Mediated Rejection in Heart Transplantation Published in Journal of the American College of Cardiology: Heart Failure
Oct 23, 2025 • Yahoo Finance
CareDx Announces Largest Landmark Study of Its Kind on Antibody Mediated Rejection in Heart Transplantation Published in Journal of the American College of Cardiology: Heart Failure
Oct 23, 2025 • Business Wire
CareDx Announces Appointment of Suresh Gunasekaran to Board of Directors
Oct 22, 2025 • MarketScreener
CareDx appoints UCSF Health CEO Suresh Gunasekaran to board
Oct 22, 2025 • Investing.com
CareDx Announces Appointment of Suresh Gunasekaran to Board of Directors
Oct 22, 2025 • Business Wire
CareDx to Report Third Quarter 2025 Financial Results on November 4, 2025
Oct 21, 2025 • Business Wire
CareDx to Report Third Quarter 2025 Financial Results on November 4, 2025
Oct 21, 2025 • Lelezard
CareDx to Report Third Quarter 2025 Financial Results on November 4, 2025
Oct 21, 2025 • Yahoo Finance
Is CareDx, Inc (NASDAQ:CDNA) Expensive For A Reason? A Look At Its Intrinsic Value
Oct 15, 2025 • Yahoo
Is CareDx, Inc (NASDAQ:CDNA) Expensive For A Reason? A Look At Its Intrinsic Value
Oct 15, 2025 • Yahoo Finance
Full 3rd Circ. Won't Rethink $45M CareDx False Ad Case
Oct 15, 2025 • Law360
CareDx, Inc. Experiences Revision in Stock Evaluation Amid Challenging Financial Metrics
Oct 15, 2025 • Markets Mojo
Law Profs Say CareDx False Ad Verdict Should Stand
Oct 6, 2025 • Law360
CareDx Announces New IVD Products and IVDR Certification for AlloSeq® Tx and QTYPE® at the 2025 American Society of Histocompatibility & Immunogenetics Annual Meeting
Oct 6, 2025 • The Joplin Globe
CareDx unveils new transplant diagnostics at ASHI 2025 meeting
Oct 6, 2025 • Investing.com
CareDx Asks 3rd Circ. To Rethink $45M False Ad Case
Sep 26, 2025 • Law360
BTIG reiterates Buy rating on CareDx stock, sees comeback in 2026
Sep 23, 2025 • Investing.com
Strs Ohio Takes Position in CareDx, Inc. $CDNA
Sep 23, 2025 • MarketBeat
4 Analysts Assess CareDx: What You Need To Know
Sep 23, 2025 • Benzinga
CDNA: BTIG Reiterates Buy Rating with Steady Price Target | CDNA Stock News
Sep 23, 2025 • GuruFocus
CareDx, Inc's (NASDAQ:CDNA) Share Price Boosted 28% But Its Business Prospects Need A Lift Too
Sep 19, 2025 • simplywall.st
Lucid Diagnostics Appoints Danielle Scelfo as Senior Vice President, Market Access & Government Affairs
Sep 16, 2025 • PR Newswire
CareDx, Inc. $CDNA Shares Bought by Acadian Asset Management LLC
Sep 14, 2025 • Defense World
CareDx stock has upside potential beyond CMS decision, BTIG says
Sep 12, 2025 • Investing.com
CareDx management to meet with BTIG
Sep 9, 2025 • thefly.com
CareDx at Wells Fargo Conference: Strategic Growth and Innovation
Sep 5, 2025 • Investing.com
CareDx Issues Comment Letter on Draft LCD Policy
Sep 2, 2025 • Business Wire
CareDx Issues Comment Letter on Draft LCD Policy
Sep 2, 2025 • Markets Financial Content
CareDx Issues Comment Letter on Draft LCD Policy
Sep 2, 2025 • MarketScreener
CareDx Battles Reimbursement Uncertainty As Market Overlooks Long-Term Potential
Aug 26, 2025 • Yahoo Finance
William Blair initiates coverage on CareDx stock with Market Perform rating
Aug 25, 2025 • Investing.com
CareDx initiated with neutral view at William Blair, here's why
Aug 25, 2025 • thefly.com
Do Options Traders Know Something About CareDx Stock We Don't?
Aug 22, 2025 • Yahoo Finance
CareDx Inc. $20.25M Securities Class Action Settlement
Aug 22, 2025 • Claim Depot
CareDx to Participate in Wells Fargo Healthcare Conference
Aug 21, 2025 • Markets Financial Content